V. Fedelešová

Effects of Long-Term Cholecalciferol Supplementation on Mineral Metabolism and Calciotropic Hormones in Chronic Kidney Disease

Z. Krivošíková, V. Spustová, K. Štefíková, 2008, Kidney and Blood Pressure Research.

Insulin resistance and vitamin D deficiency in patients with chronic kidney disease stage 2-3.

Z. Krivošíková, V. Spustová, K. Štefíková, 2011, Physiological research.

Effects of Angiotensin‐Converting Enzyme Inhibitors on Glucose and Lipid Metabolism in Essential Hypertension

M. Gajdoš, V. Spustová, R. Dzúrik, 1994, Journal of cardiovascular pharmacology.

Bopindolol: Czechoslovak experience with a new beta blocker in the treatment of hypertension.

I. Dvořák, J. Widimský, V. Fedelešová, 1991, The American journal of cardiology.

Platelet-activating effect of low-density lipoprotein and its reversal by isradipine.

R. Dzúrik, V. Fedelešová, N. Fetkovska, 1991, American journal of hypertension.

Serotonin and Platelet Activation During Treatment with Isradipine

R. Dzúrik, V. Fedelešová, N. Fetkovska, 1991, Journal of Cardiovascular Pharmacology.

Effects of Long-Term Cholecalciferol Supplementation on Mineral Metabolism and Calciotropic Hormones in Chronic Kidney Disease

V. Spustová, K. Štefíková, R. Dzúrik, 2008, Kidney and Blood Pressure Research.